Bullfrog ai announces identification of novel potential drug targets for colorectal cancer using its ai-driven bfleap™ platform

Discoveries generated by analyzing the cancer genome atlas using proprietary bfleap™ platform target validation will be conducted through partnership with j. craig venter institute (jcvi), a world-leading institution in genomics research and innovation gaithersburg, md.
BFRG Ratings Summary
BFRG Quant Ranking